Farms.com Home   News

Manitoba Agronomists Gather Online For Annual Conference

The Manitoba Agronomists Conference took place online this week.
 
Provincial Pulse Specialist Dennis Lange gave a presentation on dry beans.
 
"We ended up with about 185,000 acres of dry beans in the province, which is up from what we've seen in previous years," he said. "Most times in the last number of years, we've been kind of averaging around the 130,000 range. Definitely a lot more beans that went into the ground this year."
 
Lange expects to see a few less dry bean acres next year.
 
"We might be in that 180,000 range, a little less than what we were seeing this year, maybe even down to maybe that 160,000 range. Time will tell. Probably the biggest reasons for that is we do have competing crops. We do have crops like peas that did really well this year. We have soybeans, yields were also much better this year. We got more moisture. A lot will depend upon a grower's rotation."
 
He says one of the challenges the dry bean industry has is volunteer soybeans, which can cause shipment rejections at the bean plant. Soybeans are considered a food allergen in the dry bean markets.
 
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.